Hypertransaminasemia in pediatric celiac disease patients and its prevalence as a diagnostic clue

C Farre1, M Esteve, A Curcoy

  • 1Department of Biochemistry, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Catalonia, Spain.

Insights

Hypertransaminasemia (HT) is common in pediatric celiac disease (CD), sometimes being the only symptom. A gluten-free diet resolves liver enzyme elevations in these patients.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Celiac Disease Research

Background:

  • Hypertransaminasemia (HT), characterized by elevated liver enzymes, can be a presenting sign of pediatric celiac disease (CD).
  • Understanding the prevalence and clinical significance of HT in pediatric CD is crucial for timely diagnosis and management.

Purpose of the Study:

  • To determine the prevalence of HT in pediatric celiac disease (CD) and its association with clinical factors.
  • To assess the frequency of HT as the sole indicator of CD in children.
  • To evaluate the resolution of HT following a gluten-free diet.

Main Methods:

  • A cohort of 114 pediatric CD patients was analyzed.
  • Serological markers (antiendomysial and anti-tissue transglutaminase antibodies) and liver function tests were assessed.
  • Clinical parameters were correlated with aminotransferase levels, and outcomes after a gluten-free diet were monitored.

Main Results:

  • HT was observed in 32% of pediatric CD patients at diagnosis.
  • In 4.3% of cases, HT was the only presenting manifestation of CD.
  • Younger age was significantly associated with HT (p=0.039).
  • A gluten-free diet led to the normalization of aminotransferases in all followed patients.

Conclusions:

  • Hypertransaminasemia is a frequent finding in pediatric celiac disease and can be its sole manifestation.
  • Serological screening for CD should be considered early in the diagnostic workup of pediatric liver diseases.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...